Livongo Health (LVGO) Tops Q4 EPS by 7c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Livongo Reports Fourth Quarter and Full Year Financial Results
March 2, 2020 4:02 PM ESTStrong Full Year Revenue of $170.2 million, up 149% from 2018
Ends year with 222,700 enrolled Livongo for Diabetes Members, up 96% year-over-year2020 revenue guidance range of $280 million to $290 million
MOUNTAIN VIEW, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc.  (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its fourth quarter and full year ended December 31, 2019.
Livongo finished the year with excellent momentum, exceeding all of our guidance... More
